`
`
`
`_____________________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________
`
`APOTEX INC. AND APOTEX CORP.
`Petitioners
`
`v.
`
`CELGENE CORPORATION
`Patent Owner
`_____________________
`
`Case IPR2018-00685
`Patent 8,741,929 B2
`Issued: June 3, 2014
`
`Title: METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-
`ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
`FOR TREATMENT OF MANTLE CELL LYMPHOMAS
`
`SUBMISSION OF CASE LAW
`
`
`
`
`
`IPR2018-00685 (8,741,929 B2)
`
`Pursuant to the Board’s order, Petitioners submit the following precedent:
`
`
` In re Morsa, 713 F.3d 104, 109 (Fed. Cir. 2013)
`
` Libertad v. Welch, 53 F.3d 428, 443 n.12 (1st Cir. 1995)
`
` Buckley v. Airshield Corp., 116 F. Supp. 2d 658, 663 (D. Md. 2000)
`
`
`
`
`Dated: July 20, 2018
`STEPTOE & JOHNSON LLP
`
`1114 Avenue of the Americas
`
`New York, NY 10036
`
`
`Telephone: 212-506-3900
`
`Fax: 212-506-3950
`
`Email: lenalidomide@steptoe.com
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
` /John J. Molenda/ .
`
` John J. Molenda (Reg. No. 47,804)
`
` Vishal C. Gupta (Reg. No. 67,284)
`
` Won Seon Choi (Reg. No. 73,012)
`
` Counsel for Petitioners
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`_____________________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________
`
`APOTEX INC. AND APOTEX CORP.
`Petitioners
`
`v.
`
`CELGENE CORPORATION
`Patent Owner
`_____________________
`
`Case IPR2018-00685
`Patent 8,741,929 B2
`Issued: June 3, 2014
`
`Title: METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-
`ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
`FOR TREATMENT OF MANTLE CELL LYMPHOMAS
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned certifies that on the date indicated below a copy of the
`
`
`
`foregoing Submission of Case Law was served electronically by filing through
`
`PTAB E2E, as well as by emailing copies to counsel indicated below:
`
`F. Dominic Cerrito
`Andrew S. Chalson
`Daniel C. Wiesner
`Frank C. Calvosa
`Anthony M. Insognia
`Christopher J. Harnett
`Carey Miller, Ph.D.
`Mathew J. Hertko
`J. Patrick Elsevier, Ph.D.
`
`
`
`
`
`
`Dated: July 20, 2018
`STEPTOE & JOHNSON LLP
`
`1114 Avenue of the Americas
`
`New York, NY 10036
`
`
`Telephone: 212-506-3900
`
`Fax: 212-506-3950
`
`Email: lenalidomide@steptoe.com
`
`
`nickcerrito@quinnemanuel.com
`andrewchalson@quinnemanuel.com
`danielwiesener@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`aminsogna@jonesday.com
`charnett@jonesday.com
`cmiller@jonesday.com
`mhertko@jonesday.com
`pelsevier@celgene.com
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
` /John J. Molenda/ .
` John J. Molenda
`Lead Counsel for Petitioners
`
`
`
`